1.82
前日終値:
$1.995
開ける:
$1.78
24時間の取引高:
83,940
Relative Volume:
5.83
時価総額:
$170.55M
収益:
-
当期純損益:
-
株価収益率:
-0.7223
EPS:
-2.5197
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.62%
1か月 パフォーマンス:
-8.08%
6か月 パフォーマンス:
-18.39%
1年 パフォーマンス:
-76.36%
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ANL
Adlai Nortye Ltd Adr
|
1.82 | 68.27M | 0 | 0 | 0 | 0.00 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-09-04 | 開始されました | H.C. Wainwright | Buy |
2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr (ANL) 最新ニュース
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks
ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India
ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India
Adlai Nortye Announces Change in Auditing Firm - TipRanks
Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks
Trump Announces Nomination of Howard Lutnick to Serve as US Commerce Secretary, to Run Office of US Trade Representative - AASTOCKS.com
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive
CRVO Stock Quote Price and Forecast - CNN
Adlai Nortye Ltd Adr (ANL) 財務データ
Adlai Nortye Ltd Adr (ANL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):